Evaluating the Role of a Healing Cream in Faster Recovery from Fungal Skin Infections

A randomized, open label, prospective investigator initiated interventional study to understand the effects of addition of broad-spectrum antimicrobial skin healing cream (Silversol plus coconut oil plus vitamin E plus Hyaluronic acid) as an adjuvant to an antifungal agent in the management of superficial skin fungal infections. - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

CTRI

Registry ID

CTRI/2026/01/101218

Enrollment

100

Registered

2026-01-15

Start date

Unknown

Completion date

Unknown

Last updated

2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L089- Local infection of the skin and subcutaneous tissue, unspecified

Interventions

Intervention1: Silversol plus coconut oil plus vitamin E plus Hyaluronic acid) as an adjuvant to an antifungal agent: adjuvant to an antifungal agent in the managem skin fungal infections.Like topical

Eligibility

Inclusion criteria

Inclusion criteria: 1.Age between 18 (Completed) and 70 yrs 2.Positive for KOH test 3.Able to comply to the prescribed therapy 4.Able to give informed consent

Exclusion criteria

Exclusion criteria: 1. Patient with a known history or clinical evidence of severe cardiac, renal, or hepatic disease (in case of oral antifungal is prescribed) 2. Pregnant women (in case of oral fluconazole) 3. Systemic antibiotic use in previous 2 days 4. Corticosteroid or immunosuppressant in the past 6 weeks Any investigational drug in the previous 3 months

Design outcomes

Primary

Measure	Time frame
To observe the effect of addition of broad-spectrum antimicrobial skin healing cream to antifungal therapy on clinical and mycological cure. Total of 100 patients will be recruited (50 patients in each of the two arms). 10 weeksTimepoint: To observe the effect of addition of broad-spectrum antimicrobial skin healing cream to antifungal therapy on clinical and mycological cure. Total of 100 patients will be recruited (50 patients in each of the two arms). 10 weeks	—

Measure

Time frame

To observe the effect of addition of broad-spectrum antimicrobial skin healing cream to antifungal therapy on clinical and mycological cure. Total of 100 patients will be recruited (50 patients in each of the two arms). 10 weeksTimepoint: To observe the effect of addition of broad-spectrum antimicrobial skin healing cream to antifungal therapy on clinical and mycological cure. Total of 100 patients will be recruited (50 patients in each of the two arms). 10 weeks

—

Secondary

Measure	Time frame
NILTimepoint: NIL	—

Countries

India

Contacts

Public ContactDr D revathi

Revathi Hospital

revathi.derma@gmail.com9487541982

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026